Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinoma

被引：3
|
作者：
Hui, Yiang [1 ,2 ]
Lu, Shaolei [1 ,2 ]
Wang, Hai [1 ,2 ]
Resnick, Murray B. [1 ,2 ]
Wang, Yihong [1 ,2 ]
机构：
[1] Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA
[2] Lifespan Med Ctr, Providence, RI USA
来源：
HISTOPATHOLOGY | 2019年 / 74卷 / 02期
关键词：
breast cancer; CISH; DCIS; HER2; immunohistochemistry; BREAST-CANCER; CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; HYBRIDIZATION; RECOMMENDATIONS; RECEPTORS; EVOLUTION; RELAPSE; DCIS; RISK;
D O I：
10.1111/his.13731
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：358 / 362
页数：5
相关论文
共 50 条
  • [1] Discordant HER2 Immunohistochemical Expression and Gene Amplification by In-Situ Hybridization in Ductal Carcinoma In Situ
    Wang, Hai
    Hui, Nang
    Resnick, Murray B.
    Wang, Yihong
    LABORATORY INVESTIGATION, 2017, 97 : 77A - 77A
  • [2] Discordant HER2 Immunohistochemical Expression and Gene Amplification by In-Situ Hybridization in Ductal Carcinoma In Situ
    Wang, Hai
    Hui, Yiang
    Resnick, Murray B.
    Wang, Yihong
    MODERN PATHOLOGY, 2017, 30 : 77A - 77A
  • [3] Her2 gene status in breast"in situ" and invasive ductal carcinoma
    Cozaru, G. C.
    Mitroi, A. F.
    Aschie, M.
    Brinzan, C. S.
    Poinareanu, I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 968 - 969
  • [4] The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast
    Latta, EK
    Tjan, S
    Parkes, RK
    O'Malley, FP
    MODERN PATHOLOGY, 2002, 15 (12) : 1318 - 1325
  • [5] The prognostic role of HER2 expression in ductal breast carcinoma in situ
    Borgquist, Signe
    Zhou, Wenjing
    Jirstrom, Karin
    Amini, Rose-Marie
    Sollie, Thomas
    Sorlie, Therese
    Butt, Saima
    Blomqvist, Carl
    Warnberg, Fredrik
    CANCER RESEARCH, 2015, 75
  • [6] Elucidation of frequent HER2 overexpression in ductal carcinoma in situ
    Horimoto, Y.
    Terao, T.
    Tsutsumi, Y.
    Tanabe, M.
    Mogushi, K.
    Arakawa, A.
    Sonoue, H.
    Saito, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S131 - S132
  • [7] Significance of HER2 Protein Examination in Ductal Carcinoma In Situ
    Horimoto, Yoshiya
    Tokuda, Emi
    Arakawa, Atsushi
    Kosaka, Taijiro
    Saito, Mitsue
    Kasumi, Fujio
    JOURNAL OF SURGICAL RESEARCH, 2011, 167 (02) : E205 - E210
  • [8] The comparison of HER2 low and HER2 0 in ductal carcinoma in situ (DCIS) for breast cancer
    Kureyama, Nari
    Kusudo, Maho
    Nakakami, Akira
    Komaki, Rie
    Endo, Yuka
    Nozawa, Kazuki
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    CANCER RESEARCH, 2024, 84 (09)
  • [9] Comparative Analysis of Four Immunohistochemical Assays for HER2 Expression in Breast Carcinoma - Correlation with HER2 Gene Amplification and Perspectives for HER2 Low Expression
    Nielsen, Soren
    Wang, Diana
    Calero, Valeria Montalvo
    LaMar, Jared
    Saxena, Ashish
    Decamillis, Rina
    Stensballe, Mia
    LABORATORY INVESTIGATION, 2023, 103 (03) : S192 - S192
  • [10] The evaluation of the immunoexpression of Her2/neu oncoprotein in ductal carcinoma in situ in association with invasive ductal carcinoma of the breast
    Fota, Georgiana Luminita
    Stepan, A.
    Ciurea, Raluca Niculina
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2012, 53 (03): : 805 - 810
12345